Document is current
Any future updates will be listed below
-
Authors
Kim, Kihyun
Min, Chang-Ki
Koh, Youngil
Ishizawa, Kenichi
Kim, Sung-Hyun
Ito, Shigeki
Tanaka, Junji
Uchiyama, Michihiro
Kawano, Yawara
Kim, Jin Seok
Moreau, Philippe
Martin, Thomas
Dong, Yvonne
Risse, Marie-Laure
Suzuki, Kenshi
-
Funding
Funding for this research was provided by:
Sanofi
- License Information
-
More Information
Article History
Received: 15 February 2022
Revised: 21 April 2022
Accepted: 21 April 2022
First Online: 17 May 2022
Declarations
:
: KK reports grants from Janssen and BMS, outside the submitted work. KI reports grants from Sanofi, Novartis, AbbVie, Bayer, and SymBio; and personal fees from Takeda, Celgene, ONO, Novartis, Chugai, and Eisai, outside the submitted work. YK reports personal fees and non-financial support from Sanofi during the conduct of the study; and personal fees from Janssen, Bristol Myers Squibb, and ONO, outside the submitted work. PM reports personal fees from Sanofi during the conduct of the study; and personal fees from Celgene, Amgen, and Janssen, outside the submitted work. TM reports research support for his institution from Sanofi and Amgen. YD and M-LR are employees of Sanofi and may hold stock/shares in the company. KS reports personal fees and other support from Celgene; personal fees from Takeda, ONO, Amgen, Novartis, Sanofi, AbbVie and Janssen; personal fees and non-financial support from BMS during the conduct of the study. C-KM, YK, S-HK, SI, JT, MU, and JSK have nothing to disclose.
